Global Atropine 麻豆原创 Growth 2024-2030

Publication ID:

LPI01241945

Publication Date:

January 4, 2024

Pages:

123

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Atropine market size was valued at US$ 490.1 million in 2023. With growing demand in downstream market, the Atropine is forecast to a readjusted size of US$ 432.7 million by 2030 with a CAGR of -1.8% during review period.
The research report highlights the growth potential of the global Atropine market. Atropine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Atropine. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Atropine market.
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.
Global Atropine key players include 颁虏笔贬础搁惭础, RESONANCE LABORATORIES, ROLABO OUTSOURCING, CR Double-Crane, Katsura Chemical, etc. Global top five manufacturers hold a share about 35%. China, Europe and North America is the largest market, each with a share about 25%, followed by Japan, with a share about 15 percent. In terms of product, Injection is the largest segment, with a share about 80%. And in terms of application, the largest application is Gastrointestinal, followed by Ophthalmology, etc.
Key Features:
The report on Atropine market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Atropine market. It may include historical data, market segmentation by Type (e.g., Injection, Drop), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Atropine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Atropine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Atropine industry. This include advancements in Atropine technology, Atropine new entrants, Atropine new investment, and other innovations that are shaping the future of Atropine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Atropine market. It includes factors influencing customer ' purchasing decisions, preferences for Atropine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Atropine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Atropine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Atropine market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Atropine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Atropine market.
麻豆原创 Segmentation:
Atropine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Injection
Drop
Gel
Segmentation by application
Gastrointestinal
Ophthalmology
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
颁虏笔贬础搁惭础
RESONANCE LABORATORIES
ROLABO OUTSOURCING
Minsheng
CR Double-Crane
HENAN PURUI
Albany Molecular Research
Alchem International
SAURAV CHEMICALS
Katsura Chemical
Hangzhou Vega
Wuhan senwayer century
Key Questions Addressed in this Report
What is the 10-year outlook for the global Atropine market?
What factors are driving Atropine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Atropine market opportunities vary by end market size?
How does Atropine break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Atropine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Atropine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Atropine by Country/Region, 2019, 2023 & 2030
2.2 Atropine Segment by Type
2.2.1 Injection
2.2.2 Drop
2.2.3 Gel
2.3 Atropine Sales by Type
2.3.1 Global Atropine Sales 麻豆原创 Share by Type (2019-2024)
2.3.2 Global Atropine Revenue and 麻豆原创 Share by Type (2019-2024)
2.3.3 Global Atropine Sale Price by Type (2019-2024)
2.4 Atropine Segment by Application
2.4.1 Gastrointestinal
2.4.2 Ophthalmology
2.4.3 Other
2.5 Atropine Sales by Application
2.5.1 Global Atropine Sale 麻豆原创 Share by Application (2019-2024)
2.5.2 Global Atropine Revenue and 麻豆原创 Share by Application (2019-2024)
2.5.3 Global Atropine Sale Price by Application (2019-2024)
3 Global Atropine by Company
3.1 Global Atropine Breakdown Data by Company
3.1.1 Global Atropine Annual Sales by Company (2019-2024)
3.1.2 Global Atropine Sales 麻豆原创 Share by Company (2019-2024)
3.2 Global Atropine Annual Revenue by Company (2019-2024)
3.2.1 Global Atropine Revenue by Company (2019-2024)
3.2.2 Global Atropine Revenue 麻豆原创 Share by Company (2019-2024)
3.3 Global Atropine Sale Price by Company
3.4 Key Manufacturers Atropine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Atropine Product Location Distribution
3.4.2 Players Atropine Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Atropine by Geographic Region
4.1 World Historic Atropine 麻豆原创 Size by Geographic Region (2019-2024)
4.1.1 Global Atropine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Atropine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Atropine 麻豆原创 Size by Country/Region (2019-2024)
4.2.1 Global Atropine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Atropine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Atropine Sales Growth
4.4 APAC Atropine Sales Growth
4.5 Europe Atropine Sales Growth
4.6 Middle East & Africa Atropine Sales Growth
5 Americas
5.1 Americas Atropine Sales by Country
5.1.1 Americas Atropine Sales by Country (2019-2024)
5.1.2 Americas Atropine Revenue by Country (2019-2024)
5.2 Americas Atropine Sales by Type
5.3 Americas Atropine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Atropine Sales by Region
6.1.1 APAC Atropine Sales by Region (2019-2024)
6.1.2 APAC Atropine Revenue by Region (2019-2024)
6.2 APAC Atropine Sales by Type
6.3 APAC Atropine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Atropine by Country
7.1.1 Europe Atropine Sales by Country (2019-2024)
7.1.2 Europe Atropine Revenue by Country (2019-2024)
7.2 Europe Atropine Sales by Type
7.3 Europe Atropine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Atropine by Country
8.1.1 Middle East & Africa Atropine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Atropine Revenue by Country (2019-2024)
8.2 Middle East & Africa Atropine Sales by Type
8.3 Middle East & Africa Atropine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Atropine
10.3 Manufacturing Process Analysis of Atropine
10.4 Industry Chain Structure of Atropine
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Atropine Distributors
11.3 Atropine Customer
12 World Forecast Review for Atropine by Geographic Region
12.1 Global Atropine 麻豆原创 Size Forecast by Region
12.1.1 Global Atropine Forecast by Region (2025-2030)
12.1.2 Global Atropine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Atropine Forecast by Type
12.7 Global Atropine Forecast by Application
13 Key Players Analysis
13.1 颁虏笔贬础搁惭础
13.1.1 颁虏笔贬础搁惭础 Company Information
13.1.2 颁虏笔贬础搁惭础 Atropine Product Portfolios and Specifications
13.1.3 颁虏笔贬础搁惭础 Atropine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 颁虏笔贬础搁惭础 Main Business Overview
13.1.5 颁虏笔贬础搁惭础 Latest Developments
13.2 RESONANCE LABORATORIES
13.2.1 RESONANCE LABORATORIES Company Information
13.2.2 RESONANCE LABORATORIES Atropine Product Portfolios and Specifications
13.2.3 RESONANCE LABORATORIES Atropine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 RESONANCE LABORATORIES Main Business Overview
13.2.5 RESONANCE LABORATORIES Latest Developments
13.3 ROLABO OUTSOURCING
13.3.1 ROLABO OUTSOURCING Company Information
13.3.2 ROLABO OUTSOURCING Atropine Product Portfolios and Specifications
13.3.3 ROLABO OUTSOURCING Atropine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 ROLABO OUTSOURCING Main Business Overview
13.3.5 ROLABO OUTSOURCING Latest Developments
13.4 Minsheng
13.4.1 Minsheng Company Information
13.4.2 Minsheng Atropine Product Portfolios and Specifications
13.4.3 Minsheng Atropine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Minsheng Main Business Overview
13.4.5 Minsheng Latest Developments
13.5 CR Double-Crane
13.5.1 CR Double-Crane Company Information
13.5.2 CR Double-Crane Atropine Product Portfolios and Specifications
13.5.3 CR Double-Crane Atropine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 CR Double-Crane Main Business Overview
13.5.5 CR Double-Crane Latest Developments
13.6 HENAN PURUI
13.6.1 HENAN PURUI Company Information
13.6.2 HENAN PURUI Atropine Product Portfolios and Specifications
13.6.3 HENAN PURUI Atropine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 HENAN PURUI Main Business Overview
13.6.5 HENAN PURUI Latest Developments
13.7 Albany Molecular Research
13.7.1 Albany Molecular Research Company Information
13.7.2 Albany Molecular Research Atropine Product Portfolios and Specifications
13.7.3 Albany Molecular Research Atropine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Albany Molecular Research Main Business Overview
13.7.5 Albany Molecular Research Latest Developments
13.8 Alchem International
13.8.1 Alchem International Company Information
13.8.2 Alchem International Atropine Product Portfolios and Specifications
13.8.3 Alchem International Atropine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Alchem International Main Business Overview
13.8.5 Alchem International Latest Developments
13.9 SAURAV CHEMICALS
13.9.1 SAURAV CHEMICALS Company Information
13.9.2 SAURAV CHEMICALS Atropine Product Portfolios and Specifications
13.9.3 SAURAV CHEMICALS Atropine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 SAURAV CHEMICALS Main Business Overview
13.9.5 SAURAV CHEMICALS Latest Developments
13.10 Katsura Chemical
13.10.1 Katsura Chemical Company Information
13.10.2 Katsura Chemical Atropine Product Portfolios and Specifications
13.10.3 Katsura Chemical Atropine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Katsura Chemical Main Business Overview
13.10.5 Katsura Chemical Latest Developments
13.11 Hangzhou Vega
13.11.1 Hangzhou Vega Company Information
13.11.2 Hangzhou Vega Atropine Product Portfolios and Specifications
13.11.3 Hangzhou Vega Atropine Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hangzhou Vega Main Business Overview
13.11.5 Hangzhou Vega Latest Developments
13.12 Wuhan senwayer century
13.12.1 Wuhan senwayer century Company Information
13.12.2 Wuhan senwayer century Atropine Product Portfolios and Specifications
13.12.3 Wuhan senwayer century Atropine Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Wuhan senwayer century Main Business Overview
13.12.5 Wuhan senwayer century Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.